2026-05-08 · 2026-05 / week-1

Fermi Is Pricing Matador Before Governance Clears

Fermi Is Pricing Matador Before Governance Clears

Summary: Fermi traded at $5.12 on the latest market-data snapshot, implying about $3.22 billion of equity value for a development-stage AI power and data-center platform with no revenue-generating operations, $1.41 billion of reported assets, and a live fight over who controls the board. The disagreement is not whether power for AI compute is scarce. It is whether the stock should capitalize Project Matador's scarcity premium before tenant contracts, Phase 1 financing, governance control, and the May proxy clock are resolved.

Opportunity Ranking

Rank Idea Discovery Lane Why It May Be Best Now Evidence Freshness Catalyst Window Asymmetry Main Reason to Reject
1 Fermi proxy fight versus Project Matador premium AI power infrastructure / contested control / pre-revenue asset value FRMI traded at $5.12, down 7.9% on the session, while the March 2026 10-K shows no revenue-generating operations, $1.41 billion of assets, and 629.8 million shares outstanding. Fresh May 5 proxy filings create a live fight between a founder-led strategic-review slate and a board that says his meeting request is invalid. FRMI finance snapshot checked 2026-05-08 00:15 UTC; 10-K filed March 30, 2026; contested proxy and board response filed May 5, 2026. Definitive proxy and revocation materials, May 29 disputed meeting, possible late-June consent path, Q1 disclosures, tenant or financing updates. Negative expected value for a common-stock long proxy if governance remains unresolved and the market reanchors to assets; real upside if a valid sale process or tenant financing proof arrives. Scarce AI power capacity can deserve a large premium, and any credible tenant or sale process could gap the stock higher.
2 AES cash take-private spread utility cash merger / regulatory carry AES traded at $14.29 versus a $15.00 all-cash merger price, leaving roughly 5.0% gross spread before dividends and closing timing. AES finance snapshot checked 2026-05-07 23:59 UTC; preliminary merger proxy filed May 2026. Stockholder vote, public-utility approvals, competition approvals, and closing expected in late 2026 or early 2027. Cleaner defined cash consideration than most equity stories. The spread is visible, crowded, and more regulated carry than differentiated disagreement.
3 NXG post-rights overhang closed-end fund rights / infrastructure CEF NXG traded at $58.41 after a rights offering priced at $58.45, 92% of NAV at expiry, and issued 1.54 million shares for roughly $90 million of gross proceeds. NXG finance snapshot checked 2026-05-07 23:15 UTC; preliminary rights results published after the April 30 expiry. New-share issuance, post-rights discount behavior, and monthly distribution path. Possible cleanup if rights-event supply clears. The clean event has mostly passed, and CEF discount/NAV risk can absorb the remaining spread.
4 AquaBounty reverse-split and delisting clock microcap compliance / governance AQB traded at $0.95 with a roughly $3.7 million market cap while seeking reverse-split authority through July 31, 2026. AQB finance snapshot checked 2026-05-08 00:15 UTC; preliminary proxy screened. June 23 annual meeting, bid-price compliance, and any financing or asset-sale update. A tiny market cap can move violently on corporate actions. Liquidity and evidence quality are too weak for a desk-grade setup today.

Selected opportunity: Fermi common stock around the Project Matador control fight.

Why this one now: Fermi has fresh primary-source filings, a current tape, a dated governance clock, and a large gap between market value and reported hard assets. AES is cleaner but ordinary. NXG is mechanical but late. AquaBounty is too thin.

What should surprise the reader: The stock is already down more than 80% from the 52-week high cited by market sources, yet it still prices a multi-billion-dollar premium to reported assets while the board and founder dispute whether shareholders even have a valid near-term vote on strategic direction.

Why This Is the Best Opportunity Right Now

Fermi is the rare AI-infrastructure trade where the headline theme is strong and the equity math is still uncomfortable.

The company is building Project Matador, a private power and data-center campus in Amarillo, Texas. The scarcity case is real enough to respect. Fermi's 10-K describes a Texas Tech site, gas-generation permits, gas turbines, grid-supplied power arrangements, nuclear licensing work, and financing facilities tied to long-lead equipment. The market does not need to invent the asset.

The problem is timing and control. Fermi also says it had no revenue-generating operations and no completed power generation or compute facilities through December 31, 2025. At $5.12 and 629.8 million shares outstanding, the equity value is about $3.22 billion, or 2.3 times reported total assets and 2.9 times reported stockholders' equity. That valuation can work only if investors get fast proof that Matador converts from strategic acreage and equipment into financed, leased, cash-flowing infrastructure.

Instead, the latest hard catalyst is a governance fight.

What Should Surprise the Reader

The surprising part is not that a pre-revenue AI power platform is volatile. It should be.

The surprise is that the market is being asked to capitalize two incompatible stories at once. The founder slate argues that shareholders need a strategic review and possible sale process. The company argues the May 29 meeting request is invalid, that the former CEO was terminated for cause, and that an immediate sale could undervalue the business. Both sides point to Project Matador's strategic value. Neither side has yet delivered the evidence a $3.22 billion market cap needs most: a binding tenant and complete Phase 1 financing path that makes the equity less dependent on control drama.

The Setup

Fermi is a development-stage company built around Project Matador. The asset is ambitious: private power, data-center capacity, and a long-cycle nuclear optionality layer on one campus. The 10-K says the company had $935.3 million of property, plant and equipment, $408.5 million of cash, $1.41 billion of total assets, $317.4 million of liabilities, and $1.10 billion of stockholders' equity at December 31, 2025.

It also says the company does not expect operating revenue until it executes definitive tenant leases and begins delivering powered shells and on-site power capacity. The company warns that Phase 0 and Phase 1 capital expenditures could exceed $3 billion in aggregate, with later phases requiring substantial additional capital.

That is the financial spine of the trade. The balance sheet shows real capital formation. The income statement and risk factors show that the value is still contingent.

The governance overlay arrived on May 5. Toby Neugebauer, Fermi's co-founder and a large shareholder, filed preliminary proxy materials for a May 29 special meeting. His group is seeking board changes and a strategic review. The company responded that the request is invalid, has been rescinded by officers who assumed his former offices, and that it will file revocation and proxy materials with a white proxy card.

The Mispricing

The market appears to be pricing Fermi as if the scarcity value of AI power capacity can survive the governance process largely intact. That may be right over a multi-year horizon. It is harder to defend over the next several weeks.

The better near-term frame is narrower: FRMI is a pre-revenue infrastructure equity trading at a premium to assets while the path to board control, strategic review, tenant monetization, and financing remains unsettled.

This is not a simple "short the AI theme" argument. It is a sequencing argument. Power scarcity can be valuable, but the stock is pricing recognition before the documents prove the conversion chain.

Price

Market Level Value Timestamp / Source Why It Matters
FRMI common price $5.12 2026-05-08 00:15 UTC finance snapshot Current liquid expression of the Matador and governance thesis.
Session change -7.9% 2026-05-08 00:15 UTC finance snapshot Shows active repricing after the proxy fight entered the tape.
Session range $5.06-$5.63 2026-05-08 00:15 UTC finance snapshot The stock traded near the bottom of the session range.
Volume 19.4 million shares 2026-05-08 00:15 UTC finance snapshot Liquidity is real enough for event-driven review.
Shares outstanding 629.8 million Fermi 2025 Form 10-K Converts the stock price into about $3.22 billion of equity value.
Market capitalization at $5.12 $3.22 billion Calculation from finance snapshot and 10-K share count The market is assigning value far above reported assets.
Cash and cash equivalents $408.5 million Fermi 2025 Form 10-K Liquidity matters because the company is pre-revenue and capital intensive.
Property, plant and equipment $935.3 million Fermi 2025 Form 10-K Hard-asset base behind Project Matador.
Total assets $1.41 billion Fermi 2025 Form 10-K FRMI trades at about 2.3 times reported total assets.
Total stockholders' equity $1.10 billion Fermi 2025 Form 10-K FRMI trades at about 2.9 times reported book equity.
Revenue-generating operations None disclosed through Dec. 31, 2025 Fermi 2025 Form 10-K The valuation still depends on future conversion into tenants and power delivery.

Positioning

The ownership base is the positioning.

Neugebauer's preliminary proxy materials list 146.5 million shares beneficially owned by the founder parties, including restricted stock units, or about 23.0% of outstanding common stock using the filing's share-count base. The same filing lists directors, nominees, and executive officers as a group at 208.5 million shares, or 32.7%.

That means the trade is not controlled only by passive float. It is controlled by blocks, governance documents, proxy mechanics, and whether unaffiliated holders believe the founder's strategic-review push or the board's Fermi 2.0 plan has the better payoff.

There is also an accumulation constraint. The company's May 5 response says its charter contains REIT-protection provisions, including a redemption provision that could reduce Neugebauer's ownership position and a restriction that prevents new shareholders from accumulating more than 2.5% of outstanding stock. That makes the upside path less like a simple activist buying campaign and more like a legal and governance process.

What is missing: current short interest, borrow cost, listed-options depth, dealer gamma, and real-time holder rotation were not verified in this run. Any bearish expression must treat those as live execution risks, not footnotes.

Catalyst

The catalyst path is dated but contested.

The first clock is the May 29 special meeting that Neugebauer says he called while still chief executive officer on April 17. The company says that request is invalid and rescinded. The decisive issue is not the date alone; it is whether proxy materials, meeting validity, or a court or procedural response make the vote real.

The second clock is a possible late-June consent path. The company says Neugebauer also sought consents for a second special meeting on or about June 30. If that process advances, shareholders may get a clearer referendum on whether the stock should be valued as a sale-process candidate or as a standalone buildout company.

The third clock is operating proof. The stock needs tenant contracts, financing progress, equipment delivery, power energization, and cash-burn discipline to carry its premium. Fermi's own 10-K states that it needs full and unconditional Phase 1 funding, an executed Phase 1 tenant lease, insurance, environmental work, letters of credit, permits, and approvals before development can proceed under the lease conditions described for the Project Matador site.

Payoff Map

The primary analytical instrument is FRMI common stock, assessed from the short side. The stock is liquid, but borrow and options were not verified, so the cleanest institutional expression would be a defined-risk bearish structure only if listed options are liquid enough. If options are not liquid and borrow is expensive or unstable, the right expression is no trade until execution data improves.

For the common-stock long, the probability-weighted target is below the current price. That does not mean the stock must fall. It means the current price requires a process outcome that has not yet appeared in binding documents.

Price Target and Probability Map

Scenario Probability Target / Level Return / Payoff Time Horizon Conditions Required Evidence Quality
Top Case 20% $7.25 common price +41.6% for common long; loss for bearish expression 1 to 8 weeks A valid strategic-review process emerges, the founder or board produces a credible sale or partnership path, or a tenant/financing update materially de-risks Phase 1. Medium
Base Case 45% $4.00 common price -21.9% for common long; gain for bearish expression before borrow or option costs 2 to 10 weeks The board blocks or delays the founder process, no binding tenant or financing proof arrives, and the stock reanchors toward a smaller Matador premium above reported assets. Medium
Bottom Case 35% $2.80 common price -45.3% for common long; large gain for bearish expression before borrow or option costs 1 to 4 months Governance conflict escalates, strategic-review optionality fades, Q1 or later disclosures show continued burn without tenant conversion, or financing needs dominate the AI-power scarcity narrative. Medium / Low
Invalidation / Stop Condition n/a Sustained close above $6.25 plus filed evidence of a valid sale process, binding tenant, or materially de-risked Phase 1 financing Bearish thesis break Immediate to 8 weeks The market receives real documents, not just process claims, that justify capitalizing Matador above hard-asset value. Medium

Probability-weighted expected value: $4.23 common-stock target, or about -17.4% versus $5.12. For a bearish expression, that is a gross expected price move of roughly +17.4% before borrow, option premium, slippage, and gap risk.

Current market price / level: FRMI common at $5.12; implied equity value about $3.22 billion.

Timestamp: 2026-05-08 00:15 UTC finance snapshot.

Primary instrument: Fermi Inc. common stock, analyzed from the short side.

Alternative expressions considered: Defined-risk put spread if options are liquid; small common-stock short if borrow is available and capped; no trade until borrow, options, and proxy-validity evidence improve. A long common expression was rejected because the current price already embeds too much successful process and execution value.

Confidence: Medium / Low. The valuation and filings are clear. The process outcome, borrow market, and strategic-buyer interest are not.

What Would Prove This Wrong

This thesis fails if Fermi files evidence of a binding tenant, project-level financing, or a credible sale or partnership process that makes the $3.22 billion equity value look like a discounted entry into scarce power capacity.

It also fails if Neugebauer's slate gains a valid path to control and the market receives a binding higher-value transaction proposal. A bearish expression can be directionally right on valuation and still lose money if the next headline is a sale-process document or a strategic partner with capital.

Risk Audit

Strongest counterargument: AI power scarcity is real, and the public market may be right to value Fermi above accounting assets because permitted power capacity, turbine procurement, land control, and nuclear optionality are hard to recreate.

Most fragile assumption: The load-bearing assumption is that governance uncertainty delays recognition rather than accelerates a sale or partnership.

What the market may already know: The stock is already impaired. Market sources cited a decline of more than 80% under the former CEO's tenure, and the current price reflects visible stress.

What could make the trade lose money even if the thesis is directionally right: A short can lose on a single filing if a strategic review becomes credible, a tenant signs, a financing partner validates Phase 1, or the board and founder settle.

Liquidity / execution risks: Reported volume is strong, but borrow cost, recall risk, and options depth were not verified. A position sized without borrow discipline is not underwritten.

Leverage risks: Leverage is inappropriate. The stock can gap on proxy, financing, tenant, or legal headlines.

Information reliability risks: The company and founder filings are adversarial. Each side has incentives to frame the process in its own favor. Primary filings are reliable for stated positions, not for proving who will win.

Invalidation trigger: A sustained close above $6.25 supported by filed tenant, financing, strategic-review, or meeting-validity evidence, rather than a tape-only squeeze.

Publish / revise / reject recommendation: Publish as an event-driven bearish trade note with explicit execution caveats.

Bottom Line

Fermi is not mispriced because Project Matador is fake. The asset may be valuable. The mispricing is sequencing: the stock prices a scarce AI-power platform before governance control, tenant conversion, and Phase 1 financing are proven. At $5.12, the common asks investors to pay a large premium to reported assets while the next catalyst is a proxy fight the board says is invalid. That is an uncomfortable burden of proof for the long side.

Best Trade Strategy

The best expression is a defined-risk bearish position tied to FRMI common, preferably a put spread if listed options are liquid enough to avoid paying punitive spreads. If options are not liquid and borrow is not cheap and stable, the cleaner decision is no trade rather than an uncapped short. A common-stock short is only coherent with hard size limits, no leverage, and a process stop above $6.25 supported by filed evidence.

Sources

Source Date Use
Fermi 2025 Form 10-K 2026-03-30 Shares outstanding, cash, PP&E, total assets, liabilities, stockholders' equity, no revenue-generating operations, Project Matador financing and development risks.
Fermi Founder Parties preliminary contested proxy statement 2026-05-05 May 29 meeting proposal, board slate, ownership data, strategic-review argument, vote mechanics.
Fermi board response filed as Exhibit 99.1 2026-05-05 Board position that the May 29 meeting request is invalid, termination-for-cause framing, REIT ownership restrictions, June consent path, and Fermi 2.0 argument.
Finance snapshot used in this run 2026-05-08 00:15 UTC FRMI, AES, NXG, and AQB current prices, session ranges, volume, and market capitalization where available.
AES preliminary merger proxy 2026-05 Candidate ranking cross-check for $15.00 cash merger consideration and closing conditions.
NXG rights offering preliminary results summary 2026-05 Candidate ranking cross-check for $58.45 subscription price, 92% NAV pricing, shares issued, and gross proceeds.
AquaBounty preliminary proxy summary 2026-04 Candidate ranking cross-check for reverse-split authority and Nasdaq bid-price compliance context.

Research Quality Scorecard

The Research Quality Scorecard, editable source tables, section-17 quality gate, packaging notes, internal audit trail, and cover illustration brief are preserved in the companion meta file.